Iambic Therapeutics, Inc. — insider transactions

8 transactions on record · IAM · CIK 1997038

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
3.0 d
trade date to filing date
Largest single trade, 24m
—
Director share, 12m
0.0%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
8

Transactions

8 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative1,995,749——filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative1,141,878$0.00—filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative1,458,290$0.00—filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative1,458,290——filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative731,187$0.00—filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative742,546$0.00—filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative742,546——filing
2026-10-192026-10-163Petrocheilos George C10% OwnerConversion of derivative122,684$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

Iambic Therapeutics, Inc. insider transactions — 8 filings on record — investment.com